Treatment of patients with evidence of mast cell-mediated itch in the absence of hives with omalizumab

Kelsey L. Auyeunga Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

Brian S. Kima Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;b Mark Lebwohl Center for Neuroinflammation & Sensation, Icahn School of Medicine at Mount Sinai, New York, NY, USA;c Allen Discovery Center for Neuroimmune Interactions, Icahn School of Medicine at Mount Sinai, New York, NY, USA;d Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA;e Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence[email protected]
View further author information

Treatment of patients with evidence of mast cell-mediated itch in the absence of hives with omalizumab

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment of patients with evidence of mast cell-mediated itch in the absence of hives with omalizumab

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date